Headquartered in Ahmedabad, Banker IVF brings over three decades of clinical experience. The centre supports individuals and couples on their fertility journeys, including those with complex medical histories or prior treatment experiences. Now part of Indira IVF, Banker IVF will continue its legacy, supported by shared values, technological advancements, and an expanded capacity to serve patients across the region.

Dr. Manish Banker and his experienced team will continue to provide assisted reproductive technology (ART) and IVF services, aiming to promote consistency in patient care and clinical support. Additionally, Dr. Banker will be associated with Indira IVF as Chief Clinical Mentor, where he will offer guidance to clinical teams across the network, share insights, and support efforts to enhance overall patient experience.

This development comes amid shifting demographic trends. According to recent records from the state government, Gujarat has witnessed a 7% decline in its child population over the past decade, signalling a broader drop in birth rates. Lifestyle changes, an increase in age at marriage, deferring childbearing due to a focus on career and more highlight a rise in infertility challenges, particularly in urban areas. As awareness of fertility health grows, the need for structured and evidence-based treatment is more critical than ever. The integration of Banker IVF contributes to the wider availability of such services across the state.

Speaking on the development, Dr. Kshitiz Murdia, CEO and Whole Time Director, Indira IVF, said, “This collaboration represents a positive step in our continued efforts to make fertility care more accessible while upholding high clinical standards. Banker IVF brings valuable experience and regional understanding that, alongside Indira IVF’s operational reach and digital capabilities, can help us strengthen our support for patients across Gujarat. We’re glad to have Dr. Manish Banker associated with Indira IVF as Chief Clinical Mentor, where he will provide clinical guidance and share insights with our teams. Our shared aim is to enhance the patient journey thoughtfully and responsibly”

Dr. Manish Banker, Director, Banker IVF, said, “At Banker IVF, our goal has always been to offer patient-centric fertility care informed by clinical experience and individual needs [ Joining hands with Indira IVF opens new opportunities to scale our impact while continuing to uphold the quality and integrity that define our practice. This collaboration brings together two institutions with shared values and complementary strengths, creating a platform to advance fertility care in Gujarat and beyond. We are committed to upholding the highest standards of care while evolving to meet our patients’ growing and diverse needs”

With this addition, Indira IVF further strengthens its presence in the western region while building a network of fertility centres across the country. Now operating in over 150 locations, the organisation remains focused on expanding responsibly into new geographies and delivering standardised, evidence-based medicine that meets the evolving needs of patients nationwide.

The post Indira IVF Joins Forces with Banker IVF to Expand Fertility Care Across Gujarat appeared first on newsmantra.in l Latest news on Politics, World, Bollywood, Sports, Delhi, Jammu & Kashmir, Trending news | News Mantra.

The post Indira IVF Hospital Limited Expands Presence in Hyderabad with Gachibowli Centre appeared first on newsmantra.in l Latest news on Politics, World, Bollywood, Sports, Delhi, Jammu & Kashmir, Trending news | News Mantra.

Mumbai, October 08, 2024: Indira IVF, India’s largest fertility network, has expanded its Board of Directors as part of its strategy to accelerate growth and innovation in fertility care. This move reflects the organization’s commitment to driving new advancements and strengthening its leadership in the IVF sector. The appointed independent directors are Mr. Dalip Sehgal, former Executive Director at Hindustan Lever Limited and former MD & CEO of Godrej Hershey Foods & Beverages Limited; Mr. Abhijit Bose, Business Leader and Entrepreneur, Former Head of India at WhatsApp, Mr. Krishnamurthy Shankar, former Group Head HR – Infosys and Professor Simon Fishel, Founder and President of the CARE Fertility Group appointed as nominee director.

Dr. Kshitiz Murdia, CEO & Co-founder of Indira IVF, on the appointment, said, “This is a significant moment for Indira IVF as we continue to aim to not only grow but also transform fertility care for millions of aspiring parents. The collective expertise and leadership of our newly appointed directors will be instrumental in driving our ambitious growth and innovation agenda. Their diverse experiences will allow us to explore new frontiers in patient care, technology, and operational excellence, further solidifying our leadership in the IVF sector.”

Mr. Dalip Sehgal brings over four decades of experience in consumer goods, retail, and real estate to his role as Lead Independent Director. His leadership will sharpen business strategy, elevate brand equity, and drive marketing efforts to strengthen the brand’s presence in India and internationally.

Mr. Abhijit Bose’s appointment as an Independent Director brings cutting-edge digital leadership and entrepreneurial vision to Indira IVF. His expertise in scaling digital platforms and driving technological advancements will be critical in accelerating Indira IVF’s growth.

Professor Simon Fishel, a global pioneer in Assisted Reproductive Technology, joins as Nominee Director, bringing his wealth of clinical and research expertise. Dr. Fishel has worked in the field of Assisted Reproduction Technology/Assisted Conception for over 30 years and was part of the original pioneering IVF team led by Steptoe and Edwards that produced the World first IVF (“Test tube”) baby.

Mr. Krishnamurthy Shankar joins Indira IVF as an Independent Director of the Company will bring unparalleled leadership in organizational development and talent strategy. His expertise in building high-performance teams and driving cultural transformation will be instrumental in shaping Indira IVF’s growth and success.

Additionally, earlier last year, Mr. Rohit Bhasin with 38 years of financial expertise, joined the Advisory Board to support Indira IVF’s strategic direction.

Ashish Agrawal, Partner in the EQT Private Capital Asia advisory team and board member at Indira IVF, shared his thoughts on the appointments, saying, “We welcome our new directors to Indira IVF’s board. Their insights will help us navigate through pivotal moments that Indira IVF plans to leverage in our journey towards redefining fertility care. With their diverse expertise, we are poised to enhance our strategic initiatives and drive meaningful advancements in the industry in India and beyond.”

This move underscores Indira IVF’s commitment to innovation and excellence while strengthening its mission to provide world-class, accessible fertility treatments, empowering aspiring parents and transforming the reproductive healthcare landscape across India.

The post New Leadership, New Horizons: Indira IVF Expands Board for Strategic Growth appeared first on newsmantra.in l Latest news on Politics, World, Bollywood, Sports, Delhi, Jammu & Kashmir, Trending news | News Mantra.

Bengaluru, September 12, 2024: Indira IVF, the leading provider of infertility treatment in India, has reached a notable achievement by opening its 150th clinic. This expansion solidifies Indira IVF’s position as the country’s largest network of IVF hospitals, with a significant number of its facilities now situated in tier 2 and tier 3 cities.

The expansion of Indira IVF coincides with a pivotal moment in India’s changing fertility sector. The field is being reshaped by demographic changes and increasing demand for assisted reproductive technologies. An Ernst and Young report indicates that approximately 27.5 million couples actively trying to conceive are facing infertility issues. However, with only about 250,000 IVF cycles performed annually, there remains a significant disparity in both access and awareness. Indira IVF’s targeted growth strategy is designed to directly tackle these issues.

Dr. Ajay Murdia, Chairman of Indira IVF Group, reflecting on Indira IVF’s journey and vision, said, “Every dream of parenthood deserves a chance. Our mission has always been to make advanced fertility treatments accessible to all, transforming infertility treatment from a privilege to a right. As we celebrate our 150th centre and over 150,000 successful IVF pregnancies, we’re witnessing the realization of our vision to address the urban-rural divide in fertility care. We’re exploring innovative models to further reduce costs and increase reach. Our goal is to create a healthcare ecosystem where every individual, regardless of their background, must have the opportunity to experience the joy of parenthood. This expansion is more than just growth; it’s about transforming lives and building families across India.”

The expansion of Indira IVF is particularly timely given India’s declining fertility rates. According to a recent Lancet report, India’s Total Fertility Rate (TFR) stood at 1.91 as of 2021, falling below the replacement level of 2.1 needed to maintain population stability. This trend underscores the urgent need for accessible and effective fertility treatments, particularly in underserved areas.

Elaborating on the challenges and opportunities in smaller urban centres, Mr. Nitiz Murdia, Director and Co-Founder of Indira IVF, stated, “Our expansion into tier 2 and tier 3 cities addresses the unique fertility challenges in these areas. By establishing centres here, we’re not only offering state-of-the-art medical services but also initiating crucial dialogues about reproductive health. Our goal is to raise awareness, break stigmas, and provide hope to couples who may have felt their dreams of parenthood were out of reach. Through our outreach programs and educational initiatives, we’re empowering individuals with knowledge to take informed decisions about their fertility journey.”

Looking to the future, Dr. Kshitiz Murdia, CEO & Co-Founder of Indira IVF, outlined the organisation’s ambitious expansion plans, saying, “Indira IVF has successfully expanded its network of centres to cover a majority of districts and cities in India, ensuring advanced fertility treatments are no longer limited to only Tier 1 cities. Recognizing similar unmet needs in neighbouring countries, we responded to strong demand in Nepal by extending our services to Kathmandu, while also beginning our expansion in Bangladesh with our first centre in Dhaka. We will continue to expand further, guided by thorough assessments of local healthcare needs, patient demand, and the specific requirements of each region to ensure our services are both accessible and impactful. Our mission is to enhance access to high-quality fertility care by strategically locating our centres closer to patients, reducing travel burdens and improving their experience.”

As Indira IVF continues its growth trajectory, the organisation remains steadfast in its core mission of making infertility treatment accessible, affordable, and stigma-free for all who need it. Through a combination of strategic expansion, technological innovation, and community engagement, Indira IVF is actively shaping the future of reproductive healthcare in India and beyond. By helping more couples realize their dreams of parenthood, Indira IVF is not just growing as an organisation, but is playing a crucial role in addressing India’s evolving demographic challenges.

The post Leading Fertility Chain Indira IVF Marks 150th Center, Brings Hope to Tier 2 and 3 Cities  appeared first on newsmantra.in l Latest news on Politics, World, Bollywood, Sports, Delhi, Jammu & Kashmir, Trending news | News Mantra.